Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Fly|December 22, 2009
Identification of an RNA-dependent RNA polymerase in Drosophila establishes a common theme in RNA silencingConcetta Lipardi, Bruce M PatersonProceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Identification of an RNA-dependent RNA polymerase in Drosophila involved in RNAi and transposon suppressionConcetta Lipardi, Bruce M PatersonMethods (San Diego, Calif.)|June 28, 2003
Analysis of the 3(')-hydroxyl group in Drosophila siRNA functionQin Wei, Concetta Lipardi, Bruce M PatersonMethods in Enzymology|January 13, 2005
Analysis of short interfering RNA function in RNA interference by using Drosophila embryo extracts and schneider cellsConcetta Lipardi, Hye Jung Baek, Qin Wei, et al.Endocrinology|March 19, 2002
Differential recognition of a tyrosine-dependent signal in the basolateral and endocytic pathways of thyroid epithelial cellsConcetta Lipardi, Germana Ruggiano, Lorena Perrone, et al.Thrombosis and Haemostasis|November 23, 2023
Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled TrialsJudith Hsia, Alex C Spyropoulos, Gregory Piazza, et al.TH Open : Companion Journal to Thrombosis and Haemostasis|March 20, 2020
Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended ThromboprophylaxisAlex C Spyropoulos, Concetta Lipardi, Jianfeng Xu, et al.Journal of the American College of Cardiology|April 22, 2026
Cardiovascular Trials in Hemodialysis: Closing the Evidence GapArsalan Hamid, Paolo Raggi, Concetta Lipardi, et al.Circulation|May 8, 2023
Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical TrialGregory Piazza, Alex C Spyropoulos, Judith Hsia, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 21, 2019
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN StudyAlex C Spyropoulos, Concetta Lipardi, Jianfeng Xu, et al.Pageof 2